If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 111 - 120 of 270
A Phase 3, Multi-center, Randomized, Double-blind Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Objective
Aficamten v Placebo in Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Protocol No
CVC-CYTOKINETICS-CY6033
Categories
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
Objective
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
Protocol No
CVC-IIT-BEYERS-AMF-T2DM
Categories
REACT-AF: Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Objective
REACT-AF Monitoring AFib
Protocol No
CVC-JH-REACT-AF
Categories
Randomized Evaluation of Bromocriptine In Myocardial Recovery THerapy for Peripartum Cardiomyopathy (REBIRTH)
Objective
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
Protocol No
CVC-NHLBI-REBIRTH
Categories
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial
Objective
Revascularization Choices Among under-Represented Groups Evaluation
Protocol No
CVC-PCORI-RECHARGE-M
Categories
Cerebral Protection in Transcatheter Aortic Valve Replacement: The PROTEMBO Trial
Objective
Cerebral Protection in Transcatheter Aortic Valve Replacement
Protocol No
CVC-PROTEMBIS-PROTEMBO
Categories
A Randomized Phase III Trial of Doxorubicin + Pembrolizumab Versus Doxorubicin Alone for the Treatment of Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas
Objective
Study of immunotherapy + chemo for patients with aggressive poorly differentiated sarcomas
Protocol No
ECOG-EA7222
Brain Oxygen Optimization in Severe TBI (BOOST3): A Comparative Effectiveness Study to Test the Efficacy of a Prescribed Treatment Protocol Based on Monitoring the Partial Pressure of Brain Tissue Oxygen
Objective
Brain Oxygen Optimization in Severe TBI
Protocol No
EM-NINDS-BOOST3
Categories
A 12-Month Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Patients With Partial Lipodystrophy
Objective
Daily Subcutaneous Metreleptin Treatment in Patients With FPLD
Protocol No
ENDO-AMRYT-APG-20
Categories
Brain Alterations in Patients with Cushing's Disease: a Prospective Longitudinal Study
Objective
Cushing's Neurocognitive Study
Protocol No
ENDO-IIT-IOACHIMESCU-BACD
Categories